Compounds and methods for modulating angiotensinogen expression
AU2026205416A1Pending Publication Date: 2026-07-30IONIS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026205416
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-07-08
- Publication Date
- 2026-07-30
Smart Images
Figure 00000068_0000
Abstract
Abstract Disclosed herein are compositions and compounds comprising modified oligonucleotides for modulating AGT and modulating a RAAS pathway related disease, disorder and / or condition in an individual in need thereof. A RAAS pathway related disease, disorder and / or condition in an individual such as hypertension can be treated, ameliorated, delayed or prevented with the administration of antisense compounds targeted to AGT. Abstract
Need to check novelty before this filing date? Find Prior Art